The HIV Infection: Clarification of Its Legal Classification of Transmission and Measures to Protect Societies from Burdening Caused by Social and Medical Care Services for the Coming Decades
This article addresses issues regarding the transmission of HIV; without the combination antiretroviral treatment (cART), HIV causes a fatal outcome of those infected in most cases. First, legal issues: For years, controversial discussions have dealt with the subject of the legal classification of HIV infection, such as “… criminalization of HIV exposure might limit access to and uptake of HIV prevention services…” Based on the rule of law of a constitutional state, we explain the legal principles that serve to protect the legal rights of its citizens. The state has to protect its citizens from harm by other people. The prosecution and conviction of a specific person for a proven HIV infection are legal. Therefore, general decriminalization of HIV infection would undermine the right of thereby harmed citizens to compensation. Second, HIV prevention strategies: Based on the Test and Treatment Strategy (TASP)1, controlled studies were undertaken to find out which framework conditions could improve their benefit. We outline concepts that can help to curb the still ongoing spread of HIV: By providing early HIV diagnosis and ongoing HIV care services as part of updated education and prevention campaigns. Also, concerted, comprehensive campaigns are required to demonstrate further impacts of HIV infection: Both on the quality of life of infected individuals due to the development of non-communicable diseases and the increasing burden to societies as a whole.
References
[1]
UN News (2018) Prevention Crisis’ Is Hampering Global HIV Response, Warns Head of UNAIDS. https://news.un.org/en/story/2018/07/1015042
[2]
Kelland, K. (2018) Europe’s HIV Epidemic Growing at Alarming Rate, WHO Warns.
https://www.reuters.com/article/us-health-europe-aids/europes-hiv-epidemic-growing-at-alarming-rate-who-warns-idUSKBN1DS0W8
[3]
Cohen, J. (2018) Russia’s HIV/AIDS Epidemic Is Getting Worse, Not Better.
https://www.sciencemag.org/news/2018/06/russia-s-hivaids-epidemic-getting-worse-not-better
https://doi.org/10.1126/science.aau4003
[4]
Merson, M. and Inrig, S. (2018) Containing the Global Spread of HIV. In: Merson, M. and Inrig, S., Eds., The AIDS Pandemic, Chapter 10, Springer International Publishing, Berlin, 171-196. https://doi.org/10.1007/978-3-319-47133-4
https://link.springer.com/content/pdf/10.1007%2F978-3-319-47133-4_10.pdf
[5]
European Centre for Disease Prevention and Control/WHO Regional Office for Europe (2017) HIV/AIDS Surveillance in Europe 2017-2016 Data. ECDC, Stockholm.
http://www.euro.who.int/__data/assets/pdf_file/0007/355570/20171127-Annual_HIV_ Report.pdf?ua=1
[6]
Medicines Sans Frontiers (2018) UNAIDS Report Overlooks Significant Aspects of the Global HIV Response.
https://www.msf.org/unaids-report-overlooks-significant-aspects-global-hiv-response
[7]
UNAIDS Data 2018.
http://www.unaids.org/sites/default/files/media_asset/unaids-data-2018_en.pdf
[8]
WHO (2018) Why the HIV Epidemic Is Not Over.
http://www.who.int/hiv-aids/latest-news-and-events/why-the-hiv-epidemic-is-not-over
[9]
UNAIDS (2002) Criminal Law, Public Health and HIV Transmission: A Policy Options Paper. UNAIDS/02.12E.
http://data.unaids.org/publications/irc-pub02/jc733-criminallaw_en.pdf
[10]
Barré-Sinoussi, F., Abdool Karim, S.S., Albert, J., Bekker, L.G., Beyrer, C., Cahn, P., Godfrey-Faussett, P., et al. (2018) Expert Consensus Statement on the Science of HIV in the Context of Criminal Law. Journal of the International AIDS Society, 21, e25161. https://doi.org/10.1002/jia2.25161
[11]
European Centre for Disease Prevention and Control (ECDC) (2017) Evidence Brief: HIV and Laws and Policies in Europe. Monitoring Implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia. ECDC, Stockholm.
https://ecdc.europa.eu/sites/portal/files/documents/Dublin-EB-HIV%20and%20laws%20and% 20policies%202017%20final.pdf
[12]
WHO Europe (2004) Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia.
http://www.euro.who.int/en/health-topics/communicable-diseases/hivaids/policy/guiding-policy -documents-and-frameworks-for-whoeuropes-work-on-hiv/dublin-declaration-on-partnership-to- fighthivaids-in-europe-and-central-asia
[13]
Sah, P., Fitzpatrick, M.C., Pandey, A. and Galvani, A.P. (2017) HIV Criminalization Exacerbates Subpar Diagnosis and Treatment across the United States: Response to the “Association of HIV Diagnosis Rates and Laws Criminalizing HIV Exposure in the United States”. AIDS, 31, 2437-2439.
https://doi.org/10.1097/QAD.0000000000001636
[14]
Dennin, R.H. Sinn, A. and Du, Z. (2018) The Disregarded HIV Prevention Strategies—Their Potential to Uphold the Pandemic, and the Challenges Facing Societies. World Journal of AIDS, 8, 137-159. https://doi.org/10.4236/wja.2018.84011
[15]
Hughes, A.J., Rector, A., Jimenez, V., Brock, J. and Scheer, S. (2018) Cumulative Plasma HIV Burden Disparities among Adults in HIV Care: Implications for HIV Transmission in the Era of Treatment as Prevention. AIDS, 32, 1881-1889.
https://doi.org/10.1097/QAD.0000000000001914
[16]
UNAIDS Global HIV & AIDS Statistics—2018 Fact Sheet.
http://www.unaids.org/en/resources/fact-sheet
[17]
European Centre for Disease Prevention and Control (2015) HIV and STI Prevention among Men Who Have Sex with Men. ECDC, Stockholm.
[18]
Gourlay, A., Fox, J., Gafos, M., Fidler, S., Nwokolo, N., Clarke, A., Gilson, R., Orkin, Collins, S., Porter, K. and Hart, G. (2017) A Qualitative Study Exploring the Social and Environmental Context of Recently Acquired HIV Infection among Men Who Have Sex with Men in South-East England. BMJ Open, 7, e016494.
https://doi.org/10.1136/bmjopen-2017-016494
[19]
Sosa-Rubí, S.G., Salinas-Rodríguez, A., Montoya-Rodríguez, A.A. and Galárraga, O. (2018) The Relationship between Psychological Temporal Perspective and HIV/STI Risk Behaviors among Male Sex Workers in Mexico City. Archives of Sexual Behavior, 47, 1551-1563. https://doi.org/10.1007/s10508-017-1123-1
[20]
Porter, K., Gourlay, A., Attawell, K., Hales, D., Supervie, V., et al. (2018) Substantial Heterogeneity in Progress toward Reaching the 90-90-90 HIV Target in the WHO European Region. JAIDS Journal of Acquired Immune Deficiency Syndromes, 79, 28-37. https://doi.org/10.1097/QAI.0000000000001761
[21]
Schrimshaw, E.W., Downing, M.J. and Cohn, D.J. (2018) Reasons for Non-Disclosure of Sexual Orientation among Behaviorally Bisexual Men: Non-Disclosure as Stigma Management. Archives of Sexual Behavior, 47, 219-233.
https://doi.org/10.1007/s10508-016-0762-y
[22]
Robert Koch Institute (2018) Syphilis in Deutschland im Jahr 2017—Anstieg von Syphilis-Infektionen bei Männern, die Sex mit Männern haben, setzt sich weiter fort. Epidemiologisches Bulletin, 46, 493-504. (In German)
[23]
Pradat, P., Huleux, T., Raffi, F., Delobel, P., Valantin, M., Poizot-Martin, I., Pugliese, P., Reynes, J., Rey, D., Hoen, B., Cabie, A., Bani-Sadr, F., Cheret, A., Duvivier, C., Jacomet, C., Fresard, A., Hustache-Mathieu, L., Cotte, L. and Dat’ AIDS Study Group (2018) Incidence of New Hepatitis C Virus Infection Is Still Increasing in French MSM Living with HIV. AIDS, 32, 1077-1082.
https://doi.org/10.1097/QAD.0000000000001789
[24]
Oriolo, G., Egmond, E., Mariño, Z., Cavero, M., Navines, R., Zamarrenho, L., Solà, R., Pujol, J., Bargallo, N., Forns, X. and Martin-Santos, R. (2018) Systematic Review with Meta-Analysis: Neuroimaging in Hepatitis C Chronic Infection. Alimentary Pharmacology & Therapeutics, 47, 1238-1252. https://doi.org/10.1111/apt.14594
AVERT:31.08.18: Empowering People through Knowledge. The HIV Prevention Crisis—Increasing Knowledge through Innovation.
[27]
Harris, M., et al. (2018) Associations of Loneliness with Cognitive Function and Quality of Life (QoL) among Older HIV+ Adults. 9th International Workshop on HIV & Aging, New York, 13-14 September 2018.
[28]
Des Jarlais, D., Sypsa, V., Wiessing, L., et al. (2018) Complacency Is the New Problem: Comparative Analysis of Recent Outbreaks of HIV among Persons Who Inject Drugs in Europe and North America. 22nd International AIDS Conference, Amsterdam, 23-27 July 2018, Abstract THPEC189.
[29]
Bracchi, M., Stuart, D., Castles, R., Khoo, S., Back, D. and Boffito, M. (2015) Increasing Use of “Party Drugs” in People Living with HIV on Antiretrovirals: A Concern for Patient Safety. AIDS, 29, 1585-1592.
https://doi.org/10.1097/QAD.0000000000000786
[30]
Giorgetti, R., Tagliabraccia, A., Schifanob, F., Zaamic, S., Marinellic, E. and Busardòc, F.P. (2017) When “Chems” Meet Sex: A Rising Phenomenon Called “ChemSex”. Current Neuropharmacology, 15, 762-770.
https://doi.org/10.2174/1570159X15666161117151148
[31]
Schneider, J.A. and Bouris, A.M. (2017) Emerging and Innovative Prevention Strategies for HIV Positive Gay Men. In: Wilton, L., Ed., Understanding Prevention for HIV Positive Gay Men, Springer, New York, 193-221.
https://doi.org/10.1007/978-1-4419-0203-0_8
[32]
Drew, R.S., Rice, B., Rüütel, K., Delpech, V., Attawell, K.A., Hales, D.K., Velasco, C., Amato-Gauci, A.J., Pharris, A., Tavoschi, L. and Noori, T. (2017) HIV Continuum of Care in Europe and Central Asia. HIV Medicine, 18, 490-499.
https://doi.org/10.1111/hiv.12480
[33]
Jiang, H., Xie, N., Liu, J., Zhang, Z., Liu, L., Yao, Z., Wang, X. and Nie, S. (2015) Late HIV Diagnosis: Proposed Common Definitions and Associations with Short-Term Mortality. Medicine (Baltimore), 94, e1511.
https://doi.org/10.1097/MD.0000000000001511
[34]
Cheng, W., Tang, W., Han, Z., et al. (2016) Late Presentation of HIV Infection: Prevalence, Trends, and the Role of HIV Testing Strategies in Guangzhou, China, 2008-2013. Journal of Biomedicine and Biotechnology, 2016, Article ID 1631878.
https://doi.org/10.1155/2016/1631878
[35]
Hu, H., Yan, H., Liu, X., Xu, X., Xu, J., Qiu, T., Shi, L., Fu, G., Huan, X., McFarland, W. and Wei, Ch. (2017) Trends in Late HIV Diagnosis among Men Who Have Sex with Men in Jiangsu Province, China: Results from Four Consecutive Community-Based Surveys, 2011-2014. PLoS ONE, 12, e0172664.
https://doi.org/10.1371/journal.pone.0172664
[36]
Harper, K.N. (2017) A Decade of Learning about the HIV Reservoir: New Insights into Latent Infection. AIDS, 31, N19-N20.
https://doi.org/10.1097/QAD.0000000000001559
[37]
Brumme, Z., Sudderuddin, H., Ziemniak, C., Luzuriaga, K., Jones, B.R., Joy Jeffrey, B., Cunningham, C.K., Greenough, Th. and Persaud, D. (2018) Genetic Complexity in the Replication-Competent Latent HIV Reservoir Increases with Untreated Infection Duration in Infected Youth. .AIDS, 33, 211-218.
https://doi.org/10.1097/QAD.0000000000002045
[38]
Dailey, A.F., Hoots, B.E.H., Hall, I., Song, R., Hayes, D., Fulton Jr., P., Prejean, J., Hernandez, A.L., Koenig, L.J., Valleroy, L.A., et al. (2018) Vital Signs: Human Immunodeficiency Virus Testing and Diagnosis Delays—United States. Morbidity and Mortality Weekly Report, 66, 1300-1306.
https://doi.org/10.15585/mmwr.mm6647e1
[39]
Sanfilippo, C., Pinzone, M.R., Cambria. D., Longo, A., Palumbo, M., Di Marco, R., Condorelli, F., Nunnari, G., Malaguarnera, L. and Di Rosa, M. (2018) OAS Gene Family Expression Is Associated with HIV-Related Neurocognitive Disorders. Molecular Neurobiology, 55, 1905-1914. https://doi.org/10.1007/s12035-017-0460-3
[40]
Turner S.D., Anderson, K., Slater, M., Quigley, L., Dyck, M., Guiang, C.B., et al. (2103) Rapid Point-of-Care HIV Testing in Youth: A Systematic Review. Journal of Adolescent Health, 53, 683-691. https://doi.org/10.1016/j.jadohealth.2013.07.029
[41]
Gray, E.R., Bain, R., Varsaneux, O., Peeling, R.W., Stevens, M.M. and McKendry, R.A. (2018) p24 Revisited: A Landscape Review of Antigen Detection for Early HIV Diagnosis. AIDS, 32, 2089-2102. https://doi.org/10.1097/QAD.0000000000001982
[42]
Ruben, M.A. and Fullerton, M. (2018) Proportion of Patients Who Disclose Their Sexual Orientation to Healthcare Providers and Its Relationship to Patient Outcomes: A Meta-Analysis and Review. Patient Education and Counseling, 101, 1549-1560. https://doi.org/10.1016/j.pec.2018.05.001
[43]
Jones, D.L., Sued, O., Cecchini, D., Bofill, L., Cook, R., Lucas, M., Bordato, A., Cassetti, I., Cahn, P. and Weiss, S.M. (2016) Improving Adherence to Care among “Hard to Reach” HIV-Infected Patients in Argentina. AIDS and Behavior, 20, 987-997. https://doi.org/10.1007/s10461-015-1133-8
[44]
Hogg, R.S. (2018) Phylogenetic Analyses of Local HIV Transmission. The Lancet HIV, 5, e270-e271. https://doi.org/10.1016/S2352-3018(18)30102-4
[45]
Ahmed, S., Autrey, J., Katz, I.T., Fox, M.P., Rosen, S., Onoya, D., Bärnighausen, T., Mayer, K.H. and Bor, J. (2018) Why Do People Living with HIV Not Initiate Treatment? A Systematic Review of Qualitative Evidence from Low- and Middle-Income Countries. Social Science & Medicine, 213, 72-84.
https://doi.org/10.1016/j.socscimed.2018.05.048
[46]
Roul, H., Mary-Krause, M., Ghosn, J., Delaugerre, C., Pialoux, G,, Cuzin, L., Launay, O., Lacombe, J.M., Menard, A., De Truchis, P., Delfraissy, J.F., Weiss, L., Costagliola, D. and FHDH-ANRS CO4 (2018) CD4+ Cell Count Recovery after Combined Antiretroviral Therapy in the Modern Combined Antiretroviral Therapy Era. AIDS, 32, 2605-2614.
[47]
Palich, R., Ghosn, J., Chaillon, A., Boilet, V., Nere, M.L., Chaix, M.L., Delobel, P., Molina, J.M., Lutch, F., Bouchaud, O. , Rieux, V., Thiebaut, R., Levy, Y., Delaugerre, C., Lelievre, J.D. and VRI02/ANRS149 LIGHT Vaccine Trial Group (2018) Viral Rebound in Semen after Antiretroviral Treatment Interruption in an HIV Therapeutic Vaccine Double-Blind Trial. AIDS, 33, 279-284.
https://doi.org/10.1097/QAD.0000000000002058
[48]
Drew, R.S., et al. (2017) HIV Continuum of Care in Europe and Central Asia. HIV Medicine, 18, 490-499. https://doi.org/10.1111/hiv.12480
[49]
Wu, Z., Tang, Z., Mao, Y., et al. (2017) Testing and Linkage to HIV Care in China: A Cluster-Randomised Trial. The Lancet, 4, e55-e56.
[50]
Mu, Y., Kodidela, S., Wang, Y., Kumar, S. and Cory, T.J. (2018) The Dawn of Precision Medicine in HIV: State of the Art of Pharmacotherapy. Expert Opinion on Pharmacotherapy, 19, 1581-1595.
https://doi.org/10.1080/14656566.2018.1515916
[51]
Zablotska, I.B. and O’Connor, C.C. (2017) Preexposure Prophylaxis of HIV Infection: the Role of Clinical Practices in Ending the HIV Epidemic. Current HIV/AIDS Reports, 14, 201-210. https://doi.org/10.1007/s11904-017-0367-7
[52]
Holt, M., Lea, T., Mao, L., Kolstee, J., Zablotska, I., Duck, T., Allan, B., West, M., Lee, E., Hull, P., Grulich, A., De Wit, J. and Prestage, G. (2018) Community-Level Changes in Condom Use and Uptake of HIV Pre-Exposure Prophylaxis by Gay and Bisexual Men in Melbourne and Sydney, Australia: Results of Repeated Behavioural Surveillance in 2013-17. The Lancet HIV, 5, e448-e456.
https://doi.org/10.1016/S2352-3018(18)30072-9
[53]
Hoenig, M, Jain, S., Moore, D., Collins, D., Sun, X., Anderson, P.L. and Morris, S. (2018) Substance Use and Adherence to HIV Preexposure Prophylaxis for Men Who Have Sex with Men. Emerging Infectious Diseases, 24, 2292-2302.
https://doi.org/10.3201/eid2412.180400
[54]
European Centre for Disease Prevention and Control, WHO Regional Office for Europe (2018) HIV/AIDS Surveillance in Europe 2018-2017 Data.
https://ecdc.europa.eu/en/publications-data/hivaids-surveillance-europe-2018-2017-data
[55]
Gisslen, M., Svedhem, V., Lindborg, L., Flamholc, L., Norrgren, H., Wendahl, S., Axelsson, M. and Sonnerborg, A. (2017) Sweden, the First Country to Achieve the Joint United Nations Programme on HIV/AIDS (UNAIDS)/World Health Organization (WHO) 90-90-90 Continuum of HIV Care Targets. HIV Medicine, 18, 305-307. https://doi.org/10.1111/hiv.12431
[56]
Public Health England (2018) Progress towards Ending the HIV Epidemic in the United Kingdom: 2018 Report.
https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_ data/file/759408/HIV_annual_report_2018.pdf
